Biotest Diagnostics Corporation Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	18
ISBN Number	not applicable
Product Code	GMD04820

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Biotest Diagnostics Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1.1 List Of Tables
1.2 List of Figures
2 Company Overview
2.1 Key Information
2.2 Financial Performance
2.3 Industry Outlook In Vitro Diagnostics
3 Major Products and Services
3.1 Overview
4 Competitors
5 Locations And Subsidiaries
5.1 Head Office
6 Biotest Diagnostics Corporation Pipeline Products
6.1 Biotest Diagnostics Corporation Product Pipeline Analysis
- 6.1.1 Biotest Diagnostics Corporation Pipeline Products By Equipment Type
- 6.1.2 Biotest Diagnostics Corporation Pipeline Products By Development Stage
- 6.1.3 Biotest Diagnostics Corporation Pipeline Products By Therapy Area
6.2 Seraclone Blood Grouping Reagents
- 6.2.1 Product Description
- 6.2.2 Product Status
6.3 Rare Antisera
- 6.3.1 Product Description
- 6.3.2 Product Status
6.4 Control Sera and Red Cells
- 6.4.1 Product Description
- 6.4.2 Product Status
6.5 Biotestcell Reagent Red Cell
- 6.5.1 Product Description
- 6.5.2 Product Status
7 Appendix
7.1 Methodology
- 7.1.1 Coverage
- 7.1.2 Secondary Research
- 7.1.3 Primary Research
- 7.1.4 Expert Panel Validation
7.2 Contact Us
7.3 About Global Markets Direct
7.4 Disclaimer
1 List of Tables
Table 1: Biotest Diagnostics Corporation,Key Facts
Table 2: Biotest Diagnostics Corporation Pipeline Products by Equipment Type
Table 3: Biotest Diagnostics Corporation Pipeline Products By Development Stage
Table 4: Biotest Diagnostics Corporation Pipeline Products By Therapy Area
1.2 List of Figures
Figure 1: Biotest Diagnostics Corporation Pipeline Products By Development Stage
Figure 2: Global Markets Direct Methodology